Hello and Welcome to Patientsville.com, Your Source for all MIRALAX information. We are dedicated to provide You with MIRALAX safety information. Learn about MIRALAX serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
MIRALAX Safety Reports
Total MIRALAX reports: 31.MIRALAX FDA safety alerts: No.
Reported hospitalizations: 4.
Take MIRALAX Side Effects Survey or Share Your MIRALAX Story. Read More Here.
Health Professional from UNITED STATES reported MIRALAX problem on Feb 07, 2007. Male patient was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: dysgeusia. MIRALAX dosage: unknown. Patient recovered.
MIRALAX problem was reported by a Health Professional from UNITED STATES on Mar 02, 2007. Female patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: no adverse effect. MIRALAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Apr 05, 2007. Male patient, 82 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: faeces discoloured. MIRALAX dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN, DILANTIN, PROSCAR, LIPITOR. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on Apr 05, 2007. Male patient, 82 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: faeces discoloured. MIRALAX dosage: unknown. During the same period patient was treated with COUMADIN, ASPIRIN, DILANTIN, PROSCAR, LIPITOR. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Apr 27, 2007. Female patient, 76 years of age, was diagnosed with constipation, diarrhoea and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: cystitis, faeces discoloured, irritable bowel syndrome, malaise, viral infection. MIRALAX dosage: unknown. During the same period patient was treated with PEPTO, PREVACID, ZANTAC, SINGULAIR, ADVAIR DISKUS, LUMINAL, DYAZIDE, VITAMIN D. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on May 15, 2007. Female patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: blood potassium increased. MIRALAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Apr 25, 2007. Female patient, 74 years of age, weighting 120.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: abdominal distension, flatulence, haemorrhoidal haemorrhage, muscle spasms. MIRALAX dosage: unknown. During the same period patient was treated with MILK OF MAGNESIA, LAXATIVES. Patient recovered.
MIRALAX problem was reported by a Health Professional from UNITED STATES on May 31, 2007. Female patient, 19 years of age, weighting 135.6 lb, was diagnosed with constipation, haemosiderosis and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, alanine aminotransferase increased, alpha haemolytic streptococcal infection, anorexia, aspartate aminotransferase increased, bacterial infection, blood albumin decreased, blood alkaline phosphatase increased, blood bicarbonate decreased. MIRALAX dosage: unknown. During the same period patient was treated with EXJADE, ACIDOPHILUS, VITAMIN CAP. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on June 05, 2007. Female patient, 61 years of age, weighting 123.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: abdominal pain, faeces discoloured, haematochezia, haemorrhage, inflammation, purulence, rectal prolapse. MIRALAX dosage: unknown. During the same period patient was treated with NEXIUM, CITRUCEL. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 26, 2006. Male patient, child 10 years of age, weighting 95.00 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, anxiety, autism spectrum disorder, depression, obsessive-compulsive disorder. MIRALAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Apr 25, 2007. Female patient, 74 years of age, weighting 120.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: abdominal distension, flatulence, haemorrhoidal haemorrhage, muscle spasms. MIRALAX dosage: unknown. During the same period patient was treated with MILK OF MAGNESIA, LAXATIVES. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on June 25, 2007. Female patient was diagnosed with colonoscopy and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, melaena. MIRALAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on June 26, 2007. Female patient, 68 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: dizziness, hypertension. MIRALAX dosage: unknown. Patient recovered.
MIRALAX problem was reported by a Health Professional from UNITED STATES on June 29, 2007. Male patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased. MIRALAX dosage: unknown. Patient recovered.
Health Professional from UNITED STATES reported MIRALAX problem on June 28, 2007. Female patient, 80 years of age, weighting 145.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: diarrhoea, intentional overdose, obstruction, pain. MIRALAX dosage: unknown. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on June 26, 2007. Male patient, 63 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: overdose. MIRALAX dosage: unknown. During the same period patient was treated with ZETIA, DARVOCET, COREG, WARIFIN, LIPITOR, TRICOR, METFORMIN, VALIUM. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on July 05, 2007. Female patient, 72 years of age, weighting 112.0 lb, was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: gastrointestinal disorder, oedema peripheral. MIRALAX dosage: unknown. During the same period patient was treated with LANOXIN, POTASSIUM CHLORIDE, FUROSEMIDE, FIBERCON. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 16, 2007. Female patient was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, constipation, large intestine perforation. MIRALAX dosage: unknown. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on July 24, 2007. Female patient, 35 years of age, weighting 125.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: talipes. MIRALAX dosage: unknown. During the same period patient was treated with GLYCOLAX. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: overdose, talipes. MIRALAX dosage: unknown. During the same period patient was treated with GLYCOLAX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on July 20, 2007. Female patient, 72 years of age, weighting 112.0 lb, was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: intestinal obstruction, oedema peripheral. MIRALAX dosage: unknown. During the same period patient was treated with LANOXIN, POTASSIUM CHLORIDE, FUROSEMIDE, FIBERCON. Patient was hospitalized. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 24, 2007. Male patient, 63 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: irritable bowel syndrome, overdose. MIRALAX dosage: unknown. During the same period patient was treated with ZETIA, DARVOCET, COREG, WARIFIN, LIPITOR, TRICOR, METFORMIN. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Aug 17, 2007. Female patient, 46 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, constipation, large intestine perforation. MIRALAX dosage: unknown. During the same period patient was treated with SINGULAIR, GLUCOTROL, PAXIL. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on July 23, 2007. Female patient, 35 years of age, weighting 125.0 lb, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: overdose, talipes. MIRALAX dosage: unknown. During the same period patient was treated with GLYCOLAX. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Aug 13, 2007. Female patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: overdose, talipes. MIRALAX dosage: unknown. During the same period patient was treated with GLYCOLAX. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2007. Male patient was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: faeces discoloured, haemorrhoidal haemorrhage. MIRALAX dosage: unknown. During the same period patient was treated with COUMADIN, LASIX, AMARYL, DIETARY FIBER. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Sept 06, 2007. Female patient, weighting 175.0 lb, was diagnosed with abdominal adhesions, gastrointestinal disorder and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: oedema peripheral, skin wrinkling, weight increased. MIRALAX dosage: unknown. Patient was hospitalized. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 28, 2007. Female patient, 46 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: condition aggravated, constipation, culture positive, diverticular perforation, escherichia infection, klebsiella infection, no therapeutic response, peritonitis, pneumoperitoneum. MIRALAX dosage: unknown. During the same period patient was treated with SINGULAIR, GLUCOTROL, PAXIL, RANITIDINE, ASPIRIN, ASCORBIC ACID, ALBUTEROL, HYDROCHLOROTHIAZIDE. Patient recovered.
Consumer or non-health professional from UNITED STATES reported MIRALAX problem on Aug 30, 2007. Female patient, 72 years of age, was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: glossodynia, lip pain, lip swelling. MIRALAX dosage: unknown. During the same period patient was treated with PHENERGAN EXPECTORANT W. Patient recovered.
MIRALAX problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 04, 2007. Female patient was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: colitis ischaemic. MIRALAX dosage: unknown. During the same period patient was treated with AMITIZA. Patient was hospitalized. Patient recovered.
Physician from UNITED STATES reported MIRALAX problem on Sept 19, 2007. Female patient was diagnosed with constipation and was treated with MIRALAX. After drug was administered, patient experienced the following problems/side effects: overdose, supraventricular tachycardia. MIRALAX dosage: unknown. Patient recovered.